PPARγ inhibits cell proliferation and tumor angiogenesis, induces apoptosis and reduces invasiveness following activation by specific ligands, such as the prostaglandin D2 metabolite, 15-d-PGJ2 and rosiglitazone (Ros). This evidence concerns the gene PPARG and neoplasm.